Exosomes: Biological Pharmaceutical Nanovectors for Theranostics.

Front Bioeng Biotechnol

Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, United States.

Published: January 2022

Exosomes are natural cell-derived nanovesicles of endocytic origin that enable cellular crosstalk by transferring encapsulated molecular cargos across biological barriers, thereby holding significantly complex implications in the etiology and progression of diverse disease states. Consequently, the development of exosomes-based nano-theranostic strategies has received immense consideration for advancing therapeutic interventions and disease prognosis. Their favorable biopharmaceutical properties make exosomes a unique nanoparticulate carrier for pharmaceutical drug delivery. This review provides an update on the contemporary strategies utilizing exosomes for theranostic applications in nanomedicine. In addition, we provide a synopsis of exosomal features and insights into strategic modifications that control biodistribution. We further discuss their opportunities, merits and pitfalls for cell/tissue targeted drug delivery in personalized nanotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790084PMC
http://dx.doi.org/10.3389/fbioe.2021.808614DOI Listing

Publication Analysis

Top Keywords

drug delivery
8
exosomes
4
exosomes biological
4
biological pharmaceutical
4
pharmaceutical nanovectors
4
nanovectors theranostics
4
theranostics exosomes
4
exosomes natural
4
natural cell-derived
4
cell-derived nanovesicles
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!